Stockholders' Equity (Details) - USD ($)					3 Months Ended	9 Months Ended		12 Months Ended
	Oct. 18, 2021	Mar. 09, 2021	Feb. 11, 2021	Sep. 30, 2020	Sep. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Oct. 31, 2022	Jun. 24, 2022	Dec. 08, 2021	Feb. 11, 2020
Stockholders' Equity (Details) [Line Items]
Common stock share authorized					100,000,000	100,000,000		100,000,000
Common stock share issued					48,338,500	48,338,500		46,450,250
Preferred shares authorized					10,000,000	10,000,000		10,000,000
Sale of shares						1,714,882
Gross proceeds (in Dollars)						$ 1,030,000.00
Net proceeds (in Dollars)						990,000
Gross proceeds (in Dollars)						$ 989,704
Common stock share outstanding					48,338,500	48,338,500		46,450,250
Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Share issued					1,714,882
Before Amendment [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share authorized											50,000,000
After Amendment [Member] | Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share authorized											100,000,000
2015 Plan [Member]
Stockholders' Equity (Details) [Line Items]
Authorized issuance share					2,710	2,710
Stock option description						In addition, the number of shares that have been authorized for issuance under the 2015 Plan will be automatically increased on the first day of each fiscal year beginning on January 1, 2016 and ending on (and including) January 1, 2025, in an amount equal to the lesser of (1) 4% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, or (2) another lesser amount determined by the Company’s Board of Directors.
Shares added					1,858,010	1,858,010
Remaining shares					1,365,024	1,365,024
First Annual Anniversary [Member]
Stockholders' Equity (Details) [Line Items]
Vesting percentage for the first year						25.00%
Vesting percentage per quarter						6.25%
Holder pursuant to company issued to Holder securities [Member] | Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Gross proceeds before expenses (in Dollars)		$ 9,650,000
Holder pursuant to company issued to Holder securities [Member] | New Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price per warrant (in Dollars per share)		$ 3.56
Warrants to purchase of common stock price per share (in Dollars per share)		$ 0.65
Aggregate number of warrants		3,147,700
New warrants purchase amount (in Dollars)		$ 255,751
Holder pursuant to company issued to Holder securities [Member] | Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Gross proceeds before expenses (in Dollars)		$ 9,650,000
Non-cash warrant inducement expense (in Dollars)								$ 7,800,000
October 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Convertible preferred shares	150,000							7,500,000
Net proceeds (in Dollars)	$ 13,900,000
Gross proceeds (in Dollars)	$ 15,000,000
Exercise price per warrant (in Dollars per share)	$ 2.05
Share issued	150,000
October 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Warrants	7,500,000
Preferred stock, per share (in Dollars per share)	$ 100
Conversion price per share (in Dollars per share)	2
October 2021 Offering [Member] | Investor [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price per warrant (in Dollars per share)	$ 2.05
Preferred stock deemed dividend (in Dollars)	$ 7,166,752
2020 PIPE [Member] | Healthcare-focused U.S. Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Number of existing warrants		4,842,615
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Convertible preferred shares			2.99
Exercise price per warrant (in Dollars per share)			$ 0.01
Share issued			2,784,184
Shares issued for unregistered common warrants to purchase common stock			4,166,666
Each share of common stock and accompanying common warrant (in Dollars per share)			$ 3
Net proceeds (in Dollars)			$ 23,500,000
Gross proceeds (in Dollars)			$ 25,000,000
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Pre-funded warrants			5,549,149					5,549,149
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member] | Warrants [Member]
Stockholders' Equity (Details) [Line Items]
Pre-funded warrants			5,549,149
February 2021 Offering [Member] | Investor [Member]
Stockholders' Equity (Details) [Line Items]
Warrants			4,166,666
Exercise price per warrant (in Dollars per share)			$ 3.55
Each share of common stock and accompanying common warrant (in Dollars per share)			$ 3
2020 ATM Offering [Member]
Stockholders' Equity (Details) [Line Items]
Sale of shares								680,000
Gross proceeds (in Dollars)								$ 1,550,000
Net proceeds (in Dollars)								$ 1,480,000
Stock options [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share outstanding					2,160,027	2,160,027
October 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Warrants									7,500,000
Warrants to purchase of common stock price per share (in Dollars per share)									$ 0.377
Exercise Agreement [Member] | PIPE Financing [Member]
Stockholders' Equity (Details) [Line Items]
Warrants									3,147,700
Warrants to purchase of common stock price per share (in Dollars per share)									$ 0.377
February 2021 Offering [Member] | Healthcare-focused Institutional Investor [Member]
Stockholders' Equity (Details) [Line Items]
Warrants									4,166,666
Warrants to purchase of common stock price per share (in Dollars per share)									$ 0.377
ATM Agreement [Member]
Stockholders' Equity (Details) [Line Items]
Net proceeds (in Dollars)						$ 3,500,000
Convertible preferred shares												22.1
Replacement Awards [Member]
Stockholders' Equity (Details) [Line Items]
Share options forfeited					53,125	63,316
Share options expired					2,603	32,506
Share options granted						542,500
Replacement Awards [Member] | 2016 Stock Option Plan [Member]
Stockholders' Equity (Details) [Line Items]
Stock options						134,371
Weighted average grant date fair value (in Dollars per share)						$ 1.68
Restricted stock units [Member]
Stockholders' Equity (Details) [Line Items]
Stock units granted					25,000	730,572
Stock units vested						173,368
Stock units forfeited						35,402
Stock units outstanding						808,066
Executive Officers and Non-Employee Directors [Member] | 2020 Stock Options Plan [Member]
Stockholders' Equity (Details) [Line Items]
Common stock share authorized				1,300,000
Share issued				1,300,000
Purchase of aggregate share				1,300,000
Chief Financial Officer [Member]
Stockholders' Equity (Details) [Line Items]
Exercise price per warrant (in Dollars per share)					$ 1.08	$ 1.08
Purchase of aggregate share						210,000
2020 ATM Offering [Member] | Common Stock [Member] | H.C. Wainwright & Co., LLC [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate share (in Dollars)												$ 22,100,000
Share issued								680,000
2020 ATM Offering [Member] | Common Stock [Member] | H.C. Wainwright & Co., LLC [Member] | Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate share (in Dollars)										$ 10,650,000